DermBiont Revenue and Competitors
Estimated Revenue & Valuation
- DermBiont's estimated annual revenue is currently $6.2M per year.
- DermBiont's estimated revenue per employee is $155,000
Employee Data
- DermBiont has 40 Employees.
- DermBiont grew their employee count by -9% last year.
DermBiont's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and CBO | Reveal Email/Phone |
2 | CEO, Co-Founder | Reveal Email/Phone |
3 | Head CMC, Small Molecule Tech Operations | Reveal Email/Phone |
4 | VP Discovery and Translational Research | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Co-founder and Chief Scientific Officer | Reveal Email/Phone |
7 | Associate Director and Head Technical Documentation | Reveal Email/Phone |
8 | Chief Operating Officer | Reveal Email/Phone |
9 | Associate Director Project Management | Reveal Email/Phone |
10 | Associate Director HR/Operations | Reveal Email/Phone |
DermBiont Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is DermBiont?
DermBiont's mission is to become the world's leading precision dermatology company developing targeted topical therapeutics that treat, cure, and prevent diseases. The company aims to impact the root cause of skin diseases with biotherapeutics that repair an imbalance of the microbiome as well as through the development of targeted small molecule therapeutics with well-defined mechanisms of action. DermBiont's biotherapeutics discovery team leverages computational biology and a proprietary bioinformatics platform to identify clinically meaningful dysbiosis related to common skin diseases and mines a curated library of microbes to build a pipeline of products to treat identified dysbiosis across indications.
keywords:N/A
N/A
Total Funding
40
Number of Employees
$6.2M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.3M | 40 | -62% | $63.2M |
#2 | $4.6M | 40 | N/A | N/A |
#3 | $4.3M | 40 | 33% | $6.2M |
#4 | $10M | 40 | N/A | N/A |
#5 | $4.6M | 40 | -5% | N/A |